Related Experiment Video
Updated: Nov 14, 2025

07:07
Lung microRNA Profiling Across the Estrous Cycle in Ozone-exposed Mice
Published on: January 7, 2019
6.4K
Single cell transcriptomic analysis of murine lung development on hyperoxia-induced damage.
Maria Hurskainen1,2,3,4, Ivana Mižíková1,4, David P Cook4,5
1Sinclair Centre for Regenerative Medicine, Ottawa Hospital Research Institute, Ottawa, ON, Canada.
Nature Communications
|March 11, 2021
Summary
This study reveals how hyperoxia exposure, mimicking bronchopulmonary dysplasia (BPD), alters lung cell composition and function. It highlights inflammatory signaling as a key driver of impaired lung development in infants.
Area of Science:
- Pulmonary Medicine
- Developmental Biology
- Genomics
Background:
- Late lung development is crucial for gas exchange, and its impairment leads to bronchopulmonary dysplasia (BPD) in preterm infants.
- Single-cell RNA sequencing (scRNA-seq) offers a powerful tool to dissect cellular dynamics during development and disease.
Purpose of the Study:
- To investigate the cellular and molecular changes in lung development under normal and impaired conditions using scRNA-seq.
- To identify specific cell populations and signaling pathways affected by hyperoxia, a model for BPD.
Main Methods:
- Utilized MULTI-seq to perform scRNA-seq on over 66,000 cells from 36 mice experiencing normal or hyperoxia-induced impaired lung development.
- Validated key findings in lung tissue samples from human BPD patients.
Main Results:
- Identified dynamic cell populations, including rare cell types and progenitor cells, during lung development.
- Observed significant alterations in alveolar epithelium, stromal fibroblasts, capillary endothelium, and macrophage populations due to hyperoxia exposure.
- Pathway analysis indicated inflammatory signaling as the primary driver of hyperoxia-induced lung injury.
Conclusions:
- Single-cell analysis provides unprecedented insight into the cellular landscape of late lung development in health and disease.
- Hyperoxia significantly disrupts lung cellular composition and promotes inflammation, contributing to BPD pathogenesis.

